Individualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal Cancer
about
Individualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Individualization of Dosage of ...... f Metastatic Colorectal Cancer
@en
type
label
Individualization of Dosage of ...... f Metastatic Colorectal Cancer
@en
prefLabel
Individualization of Dosage of ...... f Metastatic Colorectal Cancer
@en
P1476
Phase II Study: Individualizat ...... f Metastatic Colorectal Cancer
@en
P17
P1813
IriGen
@en
P3098
NCT01963182
P580
2013-10-01T00:00:00Z
P582
2019-07-01T00:00:00Z